Entry level above resistance $1.11
Target price $1.34.
Bullish cross by 7&12 MA's above 34 MA
Nice step up in volume.
34.35 % Short interest could begin to get squeezed.
Company profile
Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD
Target price $1.34.
Bullish cross by 7&12 MA's above 34 MA
Nice step up in volume.
34.35 % Short interest could begin to get squeezed.
Company profile
Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD